Short answer
Teleflex Inc (TFX) filed its fiscal 2014 10-K annual report with the SEC on Feb 20, 2015.
- Top risk flagged: FDA warning letter for Arlington Heights facility in March 2014, creating manufacturing and regulatory enforcement exposure
Teleflex Inc FY2014 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Medical technology model: single-use devices for critical-care and surgical procedures, sold globally through direct sales and distributors
- New 2014 portfolio additions: Mayo Healthcare distribution acquisition, Mini-Lap micro-laparoscopic assets, and RUSCH DispoLED single-use laryngoscope handle
- New reportable-segment structure: six segments after separating Vascular, Anesthesia/Respiratory and Surgical North America
- R&D spending $61.0 million in 2014, down from $65.0 million in 2013
- FDA warning letter for Arlington Heights facility, involving quality-system, corrective-action and process-validation violations
Management Discussion & Analysis
- Revenue $1,839.8M, up 8.5% YoY from $1,696.3M, driven by acquisitions, pricing and new products
- Gross margin 51.2% vs 49.5%; SG&A margin 31.5% vs 29.6%; R&D margin 3.3% vs 3.8%
- Best segment EMEA: revenue $593.1M, operating profit $114.6M, up 30.4%; worst Anesthesia/Respiratory: revenue $222.6M, down 2.6%
- Operating cash flow $290.2M; capex $67.6M; dividends $56.3M; no shares repurchased under $300M authorization
- Outlook: restructuring savings of $28M to $35M expected; risks from European receivables, China distributor inventories and healthcare austerity
Risk Factors
- FDA warning letter for Arlington Heights facility in March 2014, creating manufacturing and regulatory enforcement exposure
- European receivables $76.2M in Italy, Spain, Portugal and Greece amid constrained credit markets
- Single-location manufacturing and distribution for key products, limiting alternatives after facility or supplier disruptions
- Competitive disruption from medical-device rivals developing products with better features, clinical outcomes or economic value
- Total consolidated indebtedness $1,068M as of December 31, 2014, constraining cash flow and financial flexibility
Generated from the filing text; verify against the original. How to read a 10-K
Other Teleflex Inc annual reports
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.